Importance of lipid management in patients with cardiovascular disease

About the event

In this video, Dr. Poveda explains the need to control lipids and in particular c-LDL to avoid

The evolution and rupture of atherosclerotic plaque in patients with dyslipidemia.

Furthermore, he reinforces that guidelines recommend the combination of Rosuvastatin with Ezetimibe in patients with dyslipidemia to achieve c-LDL targets. If you want to know more about the management of patients with dyslipidemia, watch the following video